Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

David A Moore

Showing results (81-90 of 93) with videos related to

Pageof 10
Sort By:
Nature|April 12, 2023
The evolution of non-small cell lung cancer metastases in TRACERxMaise Al Bakir, Ariana Huebner, Carlos Martínez-Ruiz, et al.
Nature|April 5, 2023
Lung adenocarcinoma promotion by air pollutantsWilliam Hill, Emilia L Lim, Clare E Weeden, et al.
NPJ Breast Cancer|May 16, 2020
Report on computational assessment of Tumor Infiltrating Lymphocytes from the International Immuno-Oncology Biomarker Working GroupMohamed Amgad, Elisabeth Specht Stovgaard, Eva Balslev, et al.
The New England Journal of Medicine|April 27, 2017
Tracking the Evolution of Non-Small-Cell Lung CancerMariam Jamal-Hanjani, Gareth A Wilson, Nicholas McGranahan, et al.
The Journal of Pathology|March 5, 2020
The path to a better biomarker: application of a risk management framework for the implementation of PD-L1 and TILs as immuno-oncology biomarkers in breast cancer clinical trials and daily practicePaula I Gonzalez-Ericsson, Elisabeth S Stovgaard, Luz F Sua, et al.
Nature|July 4, 2024
Author Correction: The evolution of lung cancer and impact of subclonal selection in TRACERxAlexander M Frankell, Michelle Dietzen, Maise Al Bakir, et al.
Nature|April 12, 2023
The evolution of lung cancer and impact of subclonal selection in TRACERxAlexander M Frankell, Michelle Dietzen, Maise Al Bakir, et al.
NPJ Breast Cancer|May 16, 2020
Pitfalls in assessing stromal tumor infiltrating lymphocytes (sTILs) in breast cancerZuzana Kos, Elvire Roblin, Rim S Kim, et al.
Nature|April 27, 2017
Phylogenetic ctDNA analysis depicts early-stage lung cancer evolutionChristopher Abbosh, Nicolai J Birkbak, Gareth A Wilson, et al.
Nature|December 21, 2017
Corrigendum: Phylogenetic ctDNA analysis depicts early-stage lung cancer evolutionChristopher Abbosh, Nicolai J Birkbak, Gareth A Wilson, et al.
Pageof 10

Showing results (81-90 of 93) with videos related to

Sort By:
Pageof 10
Nature|April 12, 2023
The evolution of non-small cell lung cancer metastases in TRACERxMaise Al Bakir, Ariana Huebner, Carlos Martínez-Ruiz, et al.
Nature|April 5, 2023
Lung adenocarcinoma promotion by air pollutantsWilliam Hill, Emilia L Lim, Clare E Weeden, et al.
NPJ Breast Cancer|May 16, 2020
Report on computational assessment of Tumor Infiltrating Lymphocytes from the International Immuno-Oncology Biomarker Working GroupMohamed Amgad, Elisabeth Specht Stovgaard, Eva Balslev, et al.
The New England Journal of Medicine|April 27, 2017
Tracking the Evolution of Non-Small-Cell Lung CancerMariam Jamal-Hanjani, Gareth A Wilson, Nicholas McGranahan, et al.
The Journal of Pathology|March 5, 2020
The path to a better biomarker: application of a risk management framework for the implementation of PD-L1 and TILs as immuno-oncology biomarkers in breast cancer clinical trials and daily practicePaula I Gonzalez-Ericsson, Elisabeth S Stovgaard, Luz F Sua, et al.
Nature|July 4, 2024
Author Correction: The evolution of lung cancer and impact of subclonal selection in TRACERxAlexander M Frankell, Michelle Dietzen, Maise Al Bakir, et al.
Nature|April 12, 2023
The evolution of lung cancer and impact of subclonal selection in TRACERxAlexander M Frankell, Michelle Dietzen, Maise Al Bakir, et al.
NPJ Breast Cancer|May 16, 2020
Pitfalls in assessing stromal tumor infiltrating lymphocytes (sTILs) in breast cancerZuzana Kos, Elvire Roblin, Rim S Kim, et al.
Nature|April 27, 2017
Phylogenetic ctDNA analysis depicts early-stage lung cancer evolutionChristopher Abbosh, Nicolai J Birkbak, Gareth A Wilson, et al.
Nature|December 21, 2017
Corrigendum: Phylogenetic ctDNA analysis depicts early-stage lung cancer evolutionChristopher Abbosh, Nicolai J Birkbak, Gareth A Wilson, et al.
Pageof 10